Hefty price for Cougarhttps://www.cougarbiotechnology.com/cb7630.html
Cougar is a PIII cancer company -
https://clinicaltrials.gov/ct2/show/NCT00887198?term=CB7630&rank=5
With an estimated completion date by 2014... So approval in 2015... for their lead compound.
Not the sexiest girl in town. 1 Billion basically! (970m)
Set the stage, set the price tag for TLN.
Take Over
So far PII (incompleted) Bi-Par = 500 millions US (570 m cdn)
Cougar 970 million PIII US (1102 m Cdn)
Pre clinical & PI (incompleted) 94 Cdn Takeda
Licensing
GlobImmune + 540 millions US (613 m cdn)
Oxford + 244 british pound (550+ Cdn)
So, either TLN gets a 600 million licensing deal for 4601 or a takeover at somewhere near Bi-Par....
Look at the deals... hard evidence of value.
Why is it trading at 20 cents?
Because Canadiens undervalue their own biotech companies.
Because there is no good reason for it to trade at 20 cents.
Question.... Do we have an offer? YES
How much is the offer? bumping up my estimate to 3,50-15$ per share....